1. Home
  2. AZTA

as of 12-05-2025 4:00pm EST

$35.05
$0.05
-0.14%
Stocks Technology Industrial Machinery/Components Nasdaq

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

Chart Type:
Time Range:
Founded: 1978 Country:
United States
United States
Employees: N/A City: BURLINGTON
Market Cap: 1.4B IPO Year: 1995
Target Price: $43.60 AVG Volume (30 days): 667.4K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.22 EPS Growth: N/A
52 Week Low/High: $23.91 - $55.63 Next Earning Date: 11-21-2025
Revenue: $593,821,000 Revenue Growth: -9.52%
Revenue Growth (this year): 6.13% Revenue Growth (next year): 5.02%

AI-Powered AZTA Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 71.43%
71.43%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Azenta Inc. (AZTA)

Marotta John

President and CEO

Sell
AZTA Sep 10, 2025

Avg Cost/Share

$29.41

Shares

316

Total Value

$9,293.56

Owned After

105,979.78

SEC Form 4

Share on Social Networks: